Source: didesign021 / Shutterstock.com Zomedica (NYSEMKT:ZOM) stock is on the rise Wednesday after the company signed a strategic restructuring agreement with Qorvo Biotechnologies. This has to do with the licensing agreement concerning the TRUFORMA line of products. Under this new agreement, Zomedica is taking over the development and manufacturing of those products. Qorvo Biotechnologies was…

Source: rafapress / Shutterstock Sometimes, the financial markets can be highly unpredictable. Reportedly, the U.S. Food and Drug Administration (FDA) lifted its partial clinical hold on Bluebird Bio’s (NASDAQ:BLUE) studies of a sickle cell disease (SCD) treatment candidate. This should, one might assume, propel BLUE stock higher. Yet, surprisingly enough, shares dropped quickly after the opening…

There’s upcoming IPOs this week that traders are going to want to keep an eye on and we’re helping with a handy list. Source: Shutterstock Initial public offerings (IPOs) seeing companies offering up shares of their stock to the public market. With it comes extra activity that can result in shares rising or falling upon…

In the 1980s, the field of genetics surged in popularity. At the time, I’m sure there were many articles promising investors that genetics stocks were on the cusp of spectacular gains. Investors who were looking for short-term payoffs then were disappointed, but now, gene editing stocks look far more promising. Researching the genetic origin behind…

In 2020, the race for the Covid-19 vaccine distorted investment inflows in the biotechnology sector. Back then, emerging biotech stocks tripled or more on hopes that they would come out with a vaccine. Buying interest in vaccine research resumed earlier this year when Covid variants emerged. Once again, markets did not learn their lesson from…